Compile Data Set for Download or QSAR
maximum 50k data
Found 467 Enz. Inhib. hit(s) with all data for entry = 3332
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397147(US10596172, Compound I-28 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397148(US10596172, Compound I-33 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397149(US10596172, Compound I-35 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397151(US10596172, Compound I-39 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397152(US10596172, Compound I-40 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397153(US10596172, Compound I-45 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397173(US10596172, Compound I-96 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM50161162(AVL-292 | CC-292 | Spebrutinib | US10596172, Compo...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397262(US10596172, Compound I-242 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397172(US10596172, Compound I-243 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397264(US10596172, Compound I-244 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397265(US10596172, Compound I-245 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397266(US10596172, Compound I-247 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397267(US10596172, Compound I-248 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397144(US10596172, Compound I-4 | US10828300, Compound I-...)
Affinity DataIC50: <10nMAssay Description:JAK3: The Omnia Assay Protocol for potency assessment against JAK3 was performed in a substantially similar manner as that described in Example 251 a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397145(US10596172, Compound I-7 | US10828300, Compound IR...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397148(US10596172, Compound I-33 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397152(US10596172, Compound I-40 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397158(US10596172, Compound I-70 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397159(US10596172, Compound I-72 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397160(US10596172, Compound I-73 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397161(US10596172, Compound I-75 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397162(US10596172, Compound I-76 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397164(US10596172, Compound I-78 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397166(US10596172, Compound I-97 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397169(US10596172, Compound I-90 | US10828300, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397181(US11351168, Compound I-116 | US9987276, Compound I...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397183(US10596172, Compound I-121 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397184(US10596172, Compound I-122 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397185(US10596172, Compound I-124 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397191(US10596172, Compound I-128 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397192(US10596172, Compound I-129 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397193(US10596172, Compound I-131 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397198(US10596172, Compound I-139 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397200(US10596172, Compound I-142 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397203(US10596172, Compound I-147 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397205(US10596172, Compound I-150 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397207(US10596172, Compound I-152 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397208(US10596172, Compound I-153 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397209(US10596172, Compound I-154 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397210(US10596172, Compound I-155 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397211(US10596172, Compound I-156 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397212(US10596172, Compound I-157 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397215(US10596172, Compound I-160 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397216(US10596172, Compound I-144 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397219(US10596172, Compound I-165 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397220(US10596172, Compound I-166 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397221(US10596172, Compound I-167 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397222(US10596172, Compound I-168 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:ITK: This example describes continuous-read kinase assays to measure inherent potency of compound against active forms of ITK enzymes as described in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397181(US11351168, Compound I-116 | US9987276, Compound I...)
Affinity DataIC50: <10nMAssay Description:EGFR (WT) and EGFR (T790M/L858R): The Omnia Assay Protocol for potency assessment against EGFR is performed as described in Example 251 above except ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 467 total ) | Next | Last >>
Jump to: